1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow SCLC: new trials by email Literature Review of SCLC trials Research Report on SCLC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TAS-116 Plus Palbociclib in Breast and Rb-null Cancer Palbociclib Oral Product, TAS-116 - Advanced Breast Cancer, Treatment-Refractory Solid Tumors | Phase 1 | Withdrawn | Brown University | 2023-09-12 | 2024-09-19 |
Endometrial Neoplasms (1) · Sarcoma (1) · Urinary Bladder Neoplasms (1)
Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Connective and Soft Tissue (1) · Urinary Bladder Diseases (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1) · Urologic Diseases (1) · Urologic Neoplasms (1)
TAS-116 (1)
Brown University (1)
United States (1)